Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
15.15
-0.23 (-1.50%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Q32 Bio Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Q32 Bio stock has a consensus rating of "Strong Buy" and an average price target of $38.75. The average 1-year stock price forecast is 155.78% higher than the current stock price, while the lowest is $13 (-14.19%) and the highest is $66 (+335.64%).

Price Target: $38.75 (+155.78%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$13$38.75$38$66
Change-14.19%+155.78%+150.83%+335.64%

Analyst Ratings

The average analyst rating for Q32 Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingDec '25Feb '26Mar '26Apr '26May '26Jul '26
Strong Buy122245
Buy000000
Hold111110
Sell000000
Strong Sell000000
Total233355

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Mizuho Securities
Mizuho Securities
Buy
Reiterates
$14$36
BuyReiterates$14$36+137.62%Jul 13, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$20$40
BuyMaintains$20$40+164.03%Jul 13, 2026
Wells Fargo
Wells Fargo
Buy
Upgrades
$66
BuyUpgrades$66+335.64%Jul 13, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
n/a
BuyInitiatesn/an/aMay 18, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$13
BuyReiterates$13-14.19%May 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.00M
from 53.74M
Decreased by -98.14%
Revenue Next Year
1.00M
from 1.00M
EPS This Year
-1.46
EPS Next Year
-1.42
from -1.46
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-6.65M-6.65M-53.74M1.00M
Revenue Growth
------98.14%
Operating Income
-36.69M-39.23M-48.26M-66.10M16.90M-36.17M
Net Income
-37.56M-42.81M-53.74M-47.73M29.82M-33.58M
EPS
------1.46
Free Cash Flow
--8.73M-41.84M-37.95M4.52M-33.50M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High5.0M
Avg1,000,000
Lown/a

Revenue Growth

Revenue Growth202620272028
High
-90.7%
Avg
-98.1%
Low
-100.0%

EPS Forecast

EPS202620272028
High-1.46
Avg-1.46
Low-1.46

EPS Growth

EPS Growth20272028
High-
Avg-
Low-